Windham Capital Partners
Venture capitalNew York · Series A–Growth · 17 people tracked
Also known as WINDHAM CAPITAL PARTNERS LLC · Windham Venture Partners
Investment thesis
Windham Venture Partners invests in healthtech companies, describing its focus as life-saving and game-changing health technology.
Source: firm website, verified Aug 3, 2026.
Team · 17 people
from the firm's website & public directories
.jpg)
%20(002)%20(1).jpg)
What they invest in
from 36 of 46 portfolio companiesHealthtech ×30Medical Devices ×16Biotech ×15Digital Health ×12AI & Machine Learning ×4Hardware ×4Consumer ×3SaaS ×3
HQs:United States×28
Who they back
founder profiles across 17 portfolio companiesFounding team size:solo founder×92 founders×8
Investments · 46 tracked
founders shown can be your intro pathBy year:2025 · 12020 · 12016 · 12015 · 36 dated
Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.
BiotechDigital HealthMental HealthMountain View, US
Amit Etkin(Founder)inAdam Savitz(Executive Officer)Nicholas C. Smith(Executive Officer)Michael Hanley(Executive Officer)Aaron Weaver(Director)Po Yu (Jeff) Chen(Director)
Co-investorsAble PartnersAlpha Wave GlobalInVivium CapitalK2 HealthVenturesKorify CapitalVivo Capital+2 more
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Craig Palmer(Executive Officer)Nadim Yared(Executive Officer, Director)Dean Bruhn-Ding(Executive Officer)John Brintnall(Executive Officer)Liz Galle(Executive Officer)
BoardGeoff Pardo(Director)
Co-investorsNew Enterprise Associates (NEA)Treo Ventures, LlcYsios CapitalHatteras Venture PartnersVensana Capital
Novocure is a global oncology company developing Tumor Treating Fields therapies, including its Optune Pax device, to treat aggressive cancers such as locally advanced pancreatic cancer.
BiotechHealthtechMedical Devices
Co-investorsPfizer Venture Investments
Andros provides data-driven provider network management solutions for healthcare organizations, offering strategic and execution support across the full network lifecycle.
Enterprise SoftwareHealthtechSaaSNew York City, US
Andrew Camel(Founder)inMike Simmons(Founder)
Co-investorsBowery CapitalMeridian Street CapitalQuesta CapitalPrimary Venture Partners
Mentorship-driven startup accelerator for health technology entrepreneurs with funding and co-working space.
Blueprint Health is a healthcare-focused accelerator that runs a three-month program helping startups gain customers, raise capital, and refine their investor pitch.
Digital HealthHealthtech
HealthtechAlpharetta, US
Carribeth Ramey(Executive Officer)Peter J. Pizzo(Executive Officer)Robert R. Singer(Executive Officer)Deborah Moore(Executive Officer)Timothy Patrick(Executive Officer, Director)Peter J. Pizzo, III(Executive Officer)
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Paul Flook(Executive Officer, Director)Gregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)Axel Scherer(Director)
BoardJustin Klein(Director)in
Co-investorsAdjuvant CapitalGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Domain AssociatesDomain Partners+2 more
Medical device company developing the HARMONI Modular Intra-Ocular System for vision optimization in cataract surgery.
Medicare Advantage plan offering culturally sensitive healthcare combining Eastern and Western medicine.
Co-investorsFigure 8 InvestmentsGV (Google Ventures)PruVen Capital Partners
Clever Care is a culturally and linguistically sensitive Medicare Advantage health plan serving Southern California that integrates Eastern and Western medicine approaches.
HealthtechInsurTechSouthern California, US
Myong Sun Lee(Executive Officer, Director)Hiep Dinh Pham(Executive Officer, Director)Dave Firdaus(Executive Officer, Director)
Co-investorsNorwest Venture PartnersGlobal Founders CapitalGV (Google Ventures)Novo HoldingsAV8 VenturesFigure 8 Investments+1 more
HealthtechRadnor, US
Guillaume Bailliard(Executive Officer, Director)David Shulkin(Director)
BoardSteven Nichtberger(Director)Amir Yaron(Director)Harlan Weisman(Director)Allon Guez(Director)
Co-investorsQuesta Capital
Coravin makes a wine-preservation system that uses a thin needle and Argon gas to pour wine without removing the cork, keeping the remaining wine fresh for weeks to years.
ConsumerDirect to ConsumerHardwareBurlington, US
Greg Lambrecht(Executive Officer, Director)Frederic Levy(Executive Officer, Director)Dave KrupinskiinNicholas Lazaris(Executive Officer, Director)Calli Prendergast(Executive Officer)Greg Lembrecht(Director)
Co-investorsAlpine MeridianNew Enterprise Associates (NEA)
New York, US
Joseph Mayer(Director)James Bradley(Director)Bharath Ganesan(Director)Richard Resnick(Executive Officer, Director)
BoardJohn Clarke(Director)inTodd Pietri(Director)
Co-investorsCardinal PartnersActivate Ventures
DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US
Victor Velculescu(Executive Officer, Director, Promoter)Peter Bach(Executive Officer)Jennifer Buechel(Executive Officer)Douglas Schenkel(Executive Officer)Nicholas Dracopoli(Executive Officer)
BoardRishi Gupta(Director)in
Co-investorsAV8 VenturesForesite CapitalIllumina VenturesMenlo VenturesOpen Field CapitalOrbiMed+3 more
Detection on the Spot technology for food allergen detection spanning industrial and consumer applications.
Co-investorsNew Enterprise Associates (NEA)
Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding.
HardwareHealthtechMedical DevicesMenlo Park, US
Rodney Perkins, M.D.(Director)William M. Facteau(Executive Officer, Director)Bernard Shay(Executive Officer)Phil Lyons(Executive Officer)Brent Edwards(Executive Officer)Greg Koskowich(Executive Officer)
Co-investorsAisling CapitalNew Enterprise Associates (NEA)Lightstone VenturesSightLine Partners
Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program.
BiotechHealthtechMedical DevicesPhiladelphia, US
Co-investorsLG Technology VenturesNovartis Venture FundOrbiMedPontifax Venture CapitalMedicxiSymBiosis
Provides functional information about mutations and drug responses to enable precision oncology treatments.
Co-investorsNovartis Venture FundSR One Capital Management
HealthtechSan Diego, US
JOSEPH Y. LUCISANO(CHIEF TECHNOLOGY OFFICER)WILLIAM H. MARKLE(PRESIDENT AND CEO)
BoardADAM E. FINE(Director)inSAMUEL V. GOEKJIAN(Director)ROBERT L. ENGLER(Director)ORVILLE G. KOLTERMAN(Director)
Sophisticated optics for illumination and enhanced visualization in surgical procedures.
HealthtechSan Francisco, US
Chris Ehrlich(Director)Philip Sawyer(Executive Officer, Director)Theresa Brandner-Allen(Executive Officer)Gigi Brison(Director)Kenneth Trauner(Executive Officer, Director)Brett Robertson(Executive Officer)
Co-investorsKleiner PerkinsValence Advantage Life Sciences
MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
John Rogers(Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)David Icke(Executive Officer, Director)
BoardMarc Singer(Director)in
Co-investorsBraemar Energy VenturesMitsui Global InvestmentOUP (Osage University Partners)North Bridge Venture Partners
Nebula Genomics offers whole genome sequencing, providing consumers with health, trait, ancestry, and oral microbiome reports based on 100% of their DNA.
BiotechConsumerDigital Health
George Church(Founder)
Co-investorsF-Prime CapitalHemi Ventures, LlcHikma Ventures
HealthtechPleasanton, US
Theodore Lamson(Director)Ted Lamson(Founder)inDavid Amerson(Executive Officer, Director)William Facteau(Director)Joshua Makower(Director)John Nehra(Director)
Co-investorsNew Enterprise Associates (NEA)
Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.
BiotechHealthtechMedical DevicesSan Jose, US
Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)Dave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)
Co-investorsCerity Partners VenturesForeground CapitalPortfoliaTreo Ventures, LlcAction Potential Venture Capital Ltd.Vertex Ventures HC
Aytu BioPharma is a pharmaceutical company developing treatments for complex central nervous system (CNS) conditions, including major depressive disorder (MDD) and ADHD.
BiotechHealthtechMountain View, US
Davis Yang(Director)Joshua Makower(Executive Officer, Director)John Nehra(Director)Stefano Curti(Executive Officer, Director)Yi Li(Director)Ryan Drant(Director)
Co-investorsRuvento Ventures Pte Ltd.
Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD).
HardwareHealthtechMedical DevicesMinneapolis, US
Martin Mayse(Co-founder)Steve Dimmer(Co-founder)Dennis Wahr(President & CEO)Lisa Flaherty(Chief Strategy Officer)Steve Sathre(Vice President of Finance)Steve Paidosh(Vice President of Operations)
Co-investorsLightstone VenturesQiming Venture Partners
PainTEQ develops minimally invasive implants (LINQ and TRAQ) made of treated, sterile bone for treating sacroiliac (SI) joint pain, positioned between conservative treatments and major surgery.
HealthtechMedical Devices
Co-investorsSignet Healthcare Partners
A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.
BiotechDigital HealthHealthtechMedical DevicesBaltimore, US
Victor Velculescu(Executive Officer, Director, Promoter)Luis A. Diaz, Jr.(Executive Officer, Director, Promoter)Lisa Kann(Executive Officer)Sam Angiuoli(Executive Officer)Felix Dawson(Director)Anthony Newton(Executive Officer)
Co-investors3B Future Health FundCatalio Capital Management, LPCo-Win VenturesNew Enterprise Associates (NEA)Vensana Capital
Stryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers.
Advanced ManufacturingHealthtechMedical Devices
Kevin Loboin
Co-investorsGefinor CapitalLumira VenturesNew Enterprise Associates (NEA)Rex Health Ventures
Revelle Aesthetics develops and commercializes the Avéli device, a precision medical technology for cellulite reduction.
FemTechMedical Devices
Eb Bright(Co-Founder and Chief Administrative Officer)Jonathan Podmore(Co-Founder and Chief Technology Officer)
Co-investorsNew Enterprise Associates (NEA)Runway Growth Capital
RxWare is a "Service as a Software" company that uses its AI-powered intelligence engine, RxWare OS, to move patients from prescription to first fill by providing real-time visibility and coordinated intervention across the patient access journey.
AI & Machine LearningDigital HealthHealthtechWilmington, US
Raeanna Lewarne(Executive Officer, Director)Shlomi Aflalo(Executive Officer, Director)Ori Karev(Director)Yishai Knobel(Executive Officer, Director)
BoardAdam Fine(Director)inGregg Dearhammer(Director)
Co-investorsVodia VenturesZORA
Science Exchange provides operational infrastructure for life sciences R&D, connecting organizations, suppliers, and workflows to streamline contracting, compliance, onboarding, and financial coordination across the research ecosystem.
BiotechEnterprise SoftwareHealthtechSaaSSan Francisco, US
Elizabeth Iorns(Founder/President & CEO; Chairman of the Board)inDan Knox(Founder & COO)inMark Layden(CEO & Chairman)
Co-investorsIndex VenturesNorwest Venture PartnersSpider CapitalUnion Square Ventures (USV)Y CombinatorCollaborative Fund+1 more
SubjectWell operates a patient network that links individuals to clinical trials and connects them with healthcare providers and pharmaceutical sponsors.
BiotechDigital HealthHealthtech
Co-investorsAsset Management CompanyATPGeekdomHealthy VenturesMartin Ventures
TailorMed provides a platform that helps patients access, afford, and stay on their prescribed medications by connecting them to financial assistance and support programs.
Digital HealthHealthtechSaaS
Adam Siton(Founder)inIsrael (Srulik) Dvorsky(Founder)in
Co-investorsAccelmed PartnersAllumia VenturesBallad VenturesBridges IsraelOSF VenturesSamsung Next+2 more
Co-investorsCorewell Health Ventures
Valera Health provides virtual mental health care for adults and children, connecting patients with vetted in-house providers who develop personalized, data-driven treatment plans.
Digital HealthHealthtechMental HealthBrooklyn, US
Thomas Tsang(Executive Officer, Director)Dr. Thomas TsangCraig Albright(Executive Officer, Director)Arick Rynearson(Director)Ofer Sharon(Director)
Co-investorsConnecticut InnovationsCorewell Health VenturesCU Healthcare Innovation FundFigure 8 InvestmentsGreyMatterMedStartr Ventures+2 more
Vergent Bioscience is a clinical-stage biotechnology company developing abenacianine (VGT-309), a tumor-targeted fluorescent imaging agent that helps surgeons see tumors in real time during minimally invasive and robotic-assisted surgery.
BiotechHealthtechMedical DevicesMinneapolis, US
Jeff Julkowski(Director)Douglas Kohrs(Director)Raymond Wong(Director)Jeffrey Yurecko(Executive Officer)John Santini(Executive Officer, Director)Anita Watkins(Director)
Co-investorsColle Capital PartnersSpring Mountain Capital
HealthtechSunnyvale, US
John Pavlidis(Executive Officer, Director)John Maroney(Director)David Gallup(Director)Michael Horzewski(Executive Officer, Director)Peter Justin Klein(Director)John Nehra(Director)
Co-investorsNew Enterprise Associates (NEA)BioStar Ventures
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Ryan Sysko(Executive Officer, Director)Suzanne Clough(Executive Officer)Kevin McRaith(President and CEO)Anand Iyer(Chief AI Officer)Chris Bergstrom(Executive Officer)Anand K. Iyer(Executive Officer)
Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCExcel Venture ManagementTCP Venture Capital+1 more
Willow makes breast pumps and pumping accessories for nursing mothers, including in-bra wearable pumps and collection cups that convert traditional electric pumps into hands-free devices.
ConsumerDirect to ConsumerFemTechHardware
Co-investorsNew Enterprise Associates (NEA)PortfoliaBoxGroupBurst CapitalGoodwater CapitalHetz Ventures+1 more
Co-investorsLightstone Ventures
Exits · 5
IPOs and acquisitions across the tracked portfolioAlconNYSE: ALCAlto NeuroscienceNYSE: ANROCVRxNASDAQ: CVRXNovoCureNASDAQ: NVCRMC10acq. by Medidata
Portfolio news
latest coverage across their companies
Willow · enstarz.com · Aug 23, 2026
NovoCure · simplywall.st · Aug 18, 2026
Alcon · marketscreener.com · Aug 17, 2026
Alto Neuroscience · finance.yahoo.com · Aug 16, 2026
Fore · technical.ly · Aug 6, 2026
Clever Care Health Plan · funderintel.com · Jul 16, 2026
Delfi Diagnostics · geekwire.com · Jul 13, 2026
CVRx · tradersunion.com · Jul 7, 2026
Frequently asked questions
- How many investments has Windham Capital Partners made?
- Windham Capital Partners has 47 tracked investments, 2 of which have exited via acquisition or IPO, including 1 dated in the last 24 months.
- What stage does Windham Capital Partners invest at?
- Windham Capital Partners invests at the Series A, Series B, Series C, Growth stages.
- What is Windham Capital Partners's typical check size?
- Windham Capital Partners typically writes checks of $1M – $5M.
- What sectors does Windham Capital Partners focus on?
- Windham Capital Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Windham Capital Partners located?
- Windham Capital Partners is headquartered in New York, US.
- Does Windham Capital Partners lead rounds?
- Yes, Windham Capital Partners leads investment rounds.
- Who does Windham Capital Partners co-invest with?
- Windham Capital Partners most often shares deals with New Enterprise Associates (NEA), Figure 8 Investments, Portfolia, among 82 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.